Topical timolol for small hemangiomas of infancy

Pediatric Dermatology

Volumn 30, Issue 2, 2013, Pages 245-249

  Moehrle, Matthias ^a,b   Léauté Labrèze, Christine ^c   Schmidt, Verena ^a   Röcken, Martin ^a   Poets, Christian F ^a   Goelz, Rangmar ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Praxisklinik Tübingen Haut und Venen   (Germany)

^c University Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TIMOLOL;

ARTICLE; CANCER INHIBITION; CAPILLARY HEMANGIOMA; CLINICAL ARTICLE; DRUG MECHANISM; FEMALE; GEL; HUMAN; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; FEMALE; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; MALE; SKIN NEOPLASMS; TIMOLOL; TREATMENT OUTCOME;

EID: 84874938491     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2012.01723.x     Document Type: Article

References (9)

1. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al., Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651.
2. Siegfried EC, Keenan WJ, Al-Jureidini S,. More on propranolol for hemangiomas of infancy. N Engl J Med 2008; 359: 26.
3. Frieden IJ, Haggstrom AN, Drolet BA, et al., Infantile hemangiomas: current knowledge, future directions: proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol 2005; 22: 383-406.
4. Singh BN, Williams FM, Whitlock RM, et al., Plasma timolol levels and systolic time intervals. Clin Pharmacol Ther 1980; 28: 159-166.
5. Korte JM, Kaila T, Saari KM,. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops. Graefes Arch Clin Exp Ophthalmol 2002; 240: 430-435.
6. Shedden AH, Laurence J, Barrish A, et al., Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE) once daily versus timolol maleate ophthalmic solution twice daily. Doc Ophthalmol 2001; 103: 73-79.
7. Williams T, Ginther WH,. Hazard of ophthalmic timolol. N Engl J Med 1982; 306: 1485-1486.
8. Guo S, Ni N,. Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution. Arch Ophthalmol 2010; 128: 255-256.
9. Pope E, Chakkittakandiyil A,. Topical timolol gel for infantile hemangiomas: a pilot study. Arch Dermatol 2010; 146: 564-565.